Trial record 1 of 1 for:    remarqable
Previous Study | Return to List | Next Study

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Biosense Webster, Inc.
ClinicalTrials.gov Identifier:
NCT01824394
First received: April 1, 2013
Last updated: July 22, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2020
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)